WO2023217556 - A SUB-ASSEMBLY FOR A MEDICAMENT DELIVERY DEVICE
National phase entry:
Publication Number
WO/2023/217556
Publication Date
16.11.2023
International Application No.
PCT/EP2023/061275
International Filing Date
28.04.2023
Title **
[English]
A SUB-ASSEMBLY FOR A MEDICAMENT DELIVERY DEVICE
[French]
SOUS-ENSEMBLE POUR DISPOSITIF D'ADMINISTRATION DE MÉDICAMENT
Applicants **
SHL MEDICAL AG
Inventors
KARLSSON, Anders
Priority Data
22173097.1
12.05.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1882 | |
| EPO | Filing, Examination, Granting | 8107 | |
| Japan | Filing, Examination, Granting | 1968 | |
| South Korea | Filing, Examination, Granting | 1691 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
18,388
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
A sub-assembly for a medicament delivery device A sub-assembly for a medicament delivery device, the sub-assembly comprising a housing (30) extending from a proximal end to a distal end along a longitudinal axis (12), and a medicament delivery member guard (40) arranged telescopically inside the housing (30), wherein the medicament delivery member guard (40) is arranged to move from a proximal position relative to the housing in which the medicament delivery member guard (40) extends from the proximal end of the housing (30) to a distal position relative to the housing (30), wherein, when in the distal position, a contact portion of the medicament delivery member guard (40) extends further from the longitudinal axis (12) than an outer surface of the proximal portion of the housing (30), so that, during an injection, contact between an injection site (20) and the outer surface of the proximal portion of the housing (30) is limited due to contact between said injection site (20) and the contact portion of the medicament delivery member guard (40), and wherein the contact portion of the medicament delivery member guard (40) comprises a protrusion (42) and the housing (30) comprises a corresponding cut-out (32) in the outer surface of the proximal portion of the housing (30), the protrusion (42) being arranged so that it extends through the corresponding20 cut-out (32) when the medicament delivery member guard (40) is in the distal position relative to the housing (30).[French]
Sous-ensemble pour dispositif d'administration de médicament, le sous-ensemble comprenant un boîtier (30) s'étendant d'une extrémité proximale à une extrémité distale le long d'un axe longitudinal (12), et une protection d'élément d'administration de médicament (40) disposée de manière télescopique à l'intérieur du boîtier (30), la protection d'élément d'administration de médicament (40) étant agencée pour se déplacer d'une position proximale par rapport au boîtier dans laquelle la protection d'élément d'administration de médicament (40) s'étend depuis l'extrémité proximale du boîtier (30) à une position distale par rapport au boîtier (30), lorsqu'elle est dans la position distale, une partie de contact de la protection d'élément d'administration de médicament (40) s'étendant plus loin de l'axe longitudinal (12) qu'une surface externe de la partie proximale du boîtier (30), de telle sorte que, pendant une injection, un contact entre un site d'injection (20) et la surface externe de la partie proximale du boîtier (30) est limité en raison du contact entre ledit site d'injection (20) et la partie de contact de la protection d'élément d'administration de médicament (40), et la partie de contact de la protection d'élément d'administration de médicament (40) comprenant une saillie (42) et le boîtier (30) comprenant une découpe correspondante (32) dans la surface externe de la partie proximale du boîtier (30), la saillie (42) étant agencée de telle sorte qu'elle s'étend à travers la découpe correspondante (32) lorsque la protection d'élément d'administration de médicament (40) est dans la position distale par rapport au boîtier (30).